In this study, DDX3X was characterized as a poor prognostic biomarker for an HCC patient cohort, and correlations of high DDX3X level with cancer metastasis and the activation of PCP signaling in HCC cells were discovered. This evidence concerns the gene DDX3X and hepatocellular carcinoma.